Insider Trading & Ownership - KAWAS LEEN

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for KAWAS LEEN
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-31
Purchase
2023-11-02
9:14 pm
Eiger BioPharmaceuticals Inc.EIGRKAWAS LEEN
10% Owner
24,332$0.26199$6,3754,391,432
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2023-10-30
4:51 pm
N/A
N/A
Eiger BioPharmaceuticals Inc.EIGRKAWAS LEEN
10% Owner
0$04,367,100
(Indirect)
View
2021-02-18
Option Award
2021-02-22
5:33 pm
N/A
2031-02-17
Athira Pharma Inc.ATHAKAWAS LEEN
President & CEO
231,000$0231,000
(Direct)
View

Ownership
2020-09-17
8:27 pm
N/A
N/A
Athira Pharma Inc.ATHAKAWAS LEEN
President & CEO
10% Owner
0$01,913,567
(Direct)
View